When the Kupffer cells from the NASH group were treated with sh-Lp-PLA2, rapamycin, or JAK2-inhibitor, we observed enhanced punctate MDC fluorescence intensity, suggesting increased autophagic activity. Here, JAK2 is linked to metabolic dysfunction-associated steatohepatitis.